Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 11Breast Neoplasms 11Obesity 8Motor Activity 7Malnutrition 6Lung Neoplasms 6Prostatic Neoplasms 5Overweight 5Colorectal Neoplasms 5Weight Loss 4Hypertension 4Stroke 3Stomach Neoplasms 3Pancreatic Neoplasms 3Heart Failure 3Diabetes Mellitus 3Cardiovascular Diseases 3Sarcopenia 2Polycystic Ovary Syndrome 2Osteoporosis 2Kidney Diseases 2Inflammation 2Heart Diseases 2Gastrointestinal Neoplasms 2Frailty 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Cachexia 2Arthritis 2

Interventions

Interviews as Topic 3Educational Status 3veliparib 2adavosertib 2Specimen Handling 2Palliative Care 2Methods 2Early Intervention, Educational 2trametinib 1spartalizumab 1siltuximab 1pembrolizumab 1pamiparib 1dinaciclib 1cabozantinib 1Temozolomide 1Pharmacogenomic Variants 1Patient Comfort 1Paclitaxel 1PT-100 dipeptide 1Nutrition Assessment 1Mindfulness-Based Stress Reduction 1Mindfulness 1Magnetic Resonance Spectroscopy 1Health Promotion 1Everolimus 1Diet Therapy 1Carboplatin 1Biopsy 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Malignant Solid Neoplasm × Nutrition Assessment × Clear all
NCT06438588 2026-05-22

Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial

Mayo Clinic

Phase NA Recruiting
10 enrolled
Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡